title: Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts.
abstract: OBJECTIVE
  The universal response of vein grafts after insertion into the arterial circulation is the development of intimal hyperplasia; smooth muscle cell proliferation and connective tissue deposition, which may be modulated in part by dysfunctional endothelial nitric oxide (NO) metabolism. This study examines the effects of single dose, local application by pluronic gel of a NO donor, S-nitroso-N-acetylpenicillamine (SNAP) and an NO synthase inhibitor nitro-L-arginine methyl ester (L-NAME) on the formation of intimal hyperplasia.
  
  
  METHODS
  Forty New Zealand white rabbits underwent jugular vein interposition grafting of the common carotid artery.
  
  
  METHODS
  Ten animals were controls, 10 animals had the outer surface of the vein graft coated with 30% pluronic gel (2.5 ml), and 10 each were immersed for 15 min prior to insertion in Ringer lactate containing 10(-3) M of SNAP or L-NAME and then had their vein grafts coated with 2.5 ml of gel containing either SNAP (10(-3) M) or L-NAME (10(-3) M), which allows for sustained delivery for up to 6 h. On the 28th post operative day, the animals were sacrificed and vein grafts were harvested for morphology by electron microscopy (SEM and TEM) and dimensional analysis by videomorphometry.
  
  
  RESULTS
  All vein grafts developed intimal hyperplasia. On SEM the vein grafts had a confluent layer of endothelial cells with multiple layers of smooth muscle cells representing intimal hyperplasia in TEM. There were no demonstrable morphological differences between the four groups. Local treatment with SNAP produced a significant 36% decrease in mean intimal thickness (72 +/- 4 microns vs. 45 +/- 4 microns; mean +/- S.E.M.; p < 0.01) without a change in medial thickness compared to gel-only treated groups (58 +/- 6 microns vs. 61 +/- 7 microns; p = ns). Inhibition of NO synthase by L-NAME had no effect on the development of intimal hyperplasia (72 +/- 4 microns vs. 79 +/- 10 microns; p = ns); medial thickness was also unchanged.
  
  
  CONCLUSIONS
  These data confirm the protective effect of NO in vascular injury and suggest that NO synthase activity is either absent or reduced to such a level that further inhibition in this short time course is not relevant to the pathophysiology of vein graft intimal hyperplasia.
authors.affiliation: Department of Surgery, Duke University Medical Center, North Carolina 27710, USA.
authors.forename: G J
authors.initials: GJ
authors.lastname: Fulton
authors.forename: M G
authors.initials: MG
authors.lastname: Davies
authors.forename: L
authors.initials: L
authors.lastname: Barber
authors.forename: J L
authors.initials: JL
authors.lastname: Gray
authors.forename: E
authors.initials: E
authors.lastname: Svendsen
authors.forename: P O
authors.initials: PO
authors.lastname: Hagen
mesh_terms: D000818:Animals; D017536:Carotid Artery, Common / Q000601:surgery; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured / Q000187:drug effects; D003094:Collagen / Q000096:biosynthesis / Q000187:drug effects / Q000648:ultrastructure; D003593:Cytoplasm / Q000187:drug effects / Q000648:ultrastructure; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000648:ultrastructure*; D005260:Female; D006965:Hyperplasia / Q000139:chemically induced; D008855:Microscopy, Electron, Scanning; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000648:ultrastructure; D019331:NG-Nitroarginine Methyl Ester / Q000008:administration & dosage*; D010396:Penicillamine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D011817:Rabbits; D014654:Vascular Patency; D014680:Veins / Q000473:pathology / Q000637:transplantation*
chemical_list: C110881:S-nitro-N-acetylpenicillamine; D003094:Collagen; D010396:Penicillamine; D019331:NG-Nitroarginine Methyl Ester